| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CARDIORES.2004.10.040 |
| P8608 | Fatcat ID | release_ev3dck2b7ndrrjvvpd7ap7x7qm |
| P698 | PubMed publication ID | 15721862 |
| P5875 | ResearchGate publication ID | 8011310 |
| P50 | author | Keith Channon | Q56420294 |
| P2093 | author name string | Jeffrey Khoo | |
| Shijie Cai | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| positive regulation of nitric-oxide synthase activity | Q14761967 | ||
| hyperglycemia | Q271993 | ||
| GTP cyclohydrolase 1 | Q1487359 | ||
| P304 | page(s) | 823-31 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells | |
| P478 | volume | 65 |
| Q37510205 | A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis |
| Q37682336 | A novel role for endothelial tetrahydrobiopterin in mitochondrial redox balance |
| Q41776091 | Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS, and heme oxygenase (HO-1) levels. |
| Q42412241 | Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure |
| Q35540257 | Antiobesogenic role of endothelial nitric oxide synthase. |
| Q37054501 | Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia |
| Q38451253 | Are reactive oxygen species still the basis for diabetic complications? |
| Q37639110 | Ascorbate reverses high glucose- and RAGE-induced leak of the endothelial permeability barrier |
| Q45855269 | Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis |
| Q37408109 | C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling |
| Q35073570 | Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia |
| Q41952038 | Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin |
| Q37406055 | Consideration of gene therapy for paediatric neurotransmitter diseases |
| Q35543543 | Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning |
| Q35757153 | Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q28578225 | Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum |
| Q36253868 | Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy. |
| Q36292861 | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
| Q61797810 | Early Effects of Hyperbaric Oxygen on Inducible Nitric Oxide Synthase Activity/Expression in Lymphocytes of Type 1 Diabetes Patients: A Prospective Pilot Study |
| Q42971825 | Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet |
| Q35947546 | Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing |
| Q38680112 | Endothelial dysfunction and vascular disease - a 30th anniversary update |
| Q46643757 | Endothelial function does not improve with high-intensity continuous exercise training in SHR: implications of eNOS uncoupling |
| Q35230816 | Endothelial nitric oxide synthase dimerization is regulated by heat shock protein 90 rather than by phosphorylation |
| Q34558249 | Enhanced oxidative stress impairs cAMP-mediated dilation by reducing Kv channel function in small coronary arteries of diabetic rats |
| Q46564566 | Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner |
| Q92983276 | GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling |
| Q51767539 | Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides. |
| Q41681187 | Gymnemasylvestre derived compounds inhibit GSH depletion and increase cGMP and nitric oxide to attenuate advanced glycation end products induced hypertrophic growth in renal tubular epithelial cells |
| Q35750972 | Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability |
| Q46341240 | High glucose-induced p53 phosphorylation contributes to impairment of endothelial antioxidant system |
| Q35494661 | Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients. |
| Q41176327 | Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms |
| Q35830289 | Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. |
| Q36521250 | Hyperglycemia in acute ischemic stroke: a vascular perspective. |
| Q34569354 | Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice |
| Q34875396 | Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury |
| Q36617640 | In utero exposure to benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life. |
| Q46731892 | Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin |
| Q36753476 | Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension |
| Q33889586 | Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine |
| Q92034646 | Modification of DNA structure by reactive nitrogen species as a result of 2-methoxyestradiol-induced neuronal nitric oxide synthase uncoupling in metastatic osteosarcoma cells |
| Q34022332 | Molecular insights and therapeutic targets for diabetic endothelial dysfunction |
| Q38599441 | Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder. |
| Q35642646 | Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. |
| Q33631400 | Nitric Oxide Exerts Basal and Insulin-Dependent Anorexigenic Actions in POMC Hypothalamic Neurons |
| Q58863635 | Nitric Oxide in Vascular Damage and Regeneration |
| Q37987724 | Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q37823027 | Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling |
| Q37867946 | Oxidative stress and endothelial dysfunction in hypertension |
| Q46511733 | Pretreatment with Astragaloside IV protects human umbilical vein endothelial cells from hydrogen peroxide induced oxidative stress and cell dysfunction via inhibiting eNOS uncoupling and NADPH oxidase - ROS - NF-κB pathway |
| Q39638681 | Propofol attenuates high glucose-induced superoxide anion accumulation in human umbilical vein endothelial cells |
| Q38966160 | Propofol inhibits high glucose-induced PP2A expression in human umbilical vein endothelial cells |
| Q43241942 | Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells |
| Q47884254 | Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury |
| Q42448839 | Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine |
| Q34980958 | Protein engineering to develop a redox insensitive endothelial nitric oxide synthase |
| Q39916287 | Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression |
| Q37294875 | Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. |
| Q36440894 | Recent advances in understanding endothelial dysfunction in atherosclerosis |
| Q64080512 | Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ |
| Q30363035 | Regulation of obesity and insulin resistance by nitric oxide |
| Q26772291 | Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia |
| Q34254651 | Roles of tetrahydrobiopterin in promoting tumor angiogenesis |
| Q37193196 | Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer |
| Q37264364 | Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. |
| Q37947602 | Targeting endothelial dysfunction in vascular complications associated with diabetes |
| Q33631135 | Tetrahydrobiopterin activates brown adipose tissue and regulates systemic energy metabolism. |
| Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
| Q35751821 | The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. |
| Q30352122 | Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? |
| Q35905038 | Xiaokening stimulates endothelial nitric oxide release in diabetic rats |
Search more.